These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28917537)
1. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered. Pyrski M; Rugowska A; Wierzbiński KR; Kasprzyk A; Bogusiewicz M; Bociąg P; Samardakiewicz S; Czyż M; Kurpisz M; Pniewski T Vaccine; 2017 Oct; 35(42):5714-5721. PubMed ID: 28917537 [TBL] [Abstract][Full Text] [Related]
2. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety. Schödel F; Peterson D; Milich D Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676 [TBL] [Abstract][Full Text] [Related]
4. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic. Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884 [TBL] [Abstract][Full Text] [Related]
5. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes. Schödel F; Peterson D; Hughes J; Wirtz R; Milich D J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391 [TBL] [Abstract][Full Text] [Related]
6. [Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice]. Huang Z; Lu S; Liu N Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):456-9. PubMed ID: 11715443 [TBL] [Abstract][Full Text] [Related]
7. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136 [TBL] [Abstract][Full Text] [Related]
9. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. Milich DR; Chen MK; Hughes JL; Jones JE J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465 [TBL] [Abstract][Full Text] [Related]
10. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. Riedl P; Stober D; Oehninger C; Melber K; Reimann J; Schirmbeck R J Immunol; 2002 May; 168(10):4951-9. PubMed ID: 11994446 [TBL] [Abstract][Full Text] [Related]
11. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953 [TBL] [Abstract][Full Text] [Related]
12. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera. Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838 [TBL] [Abstract][Full Text] [Related]
13. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens. Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598 [TBL] [Abstract][Full Text] [Related]
14. Parenteral-Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B. Pyrski M; Mieloch AA; Plewiński A; Basińska-Barczak A; Gryciuk A; Bociąg P; Murias M; Rybka JD; Pniewski T Vaccines (Basel); 2019 Dec; 7(4):. PubMed ID: 31835350 [TBL] [Abstract][Full Text] [Related]
15. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice. Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581 [TBL] [Abstract][Full Text] [Related]
16. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits. Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891 [TBL] [Abstract][Full Text] [Related]
17. Erratum to "characterization and diagnostic potential of hepatitis B virus nucleocapsid expressed in E. coli and P. pastoris". Watelet B; Quibriac M; Rolland D; Gervasi G; Gauthier M; Jolivet M; Letourneur O J Virol Methods; 2002 Apr; 102(1-2):175-90. PubMed ID: 11879706 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco. Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233 [TBL] [Abstract][Full Text] [Related]
19. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo. Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782 [TBL] [Abstract][Full Text] [Related]
20. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection. Milich DR J Viral Hepat; 1997; 4 Suppl 2():48-59. PubMed ID: 9429210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]